Giant cell myocarditis in the CMR era by Leong, Tora et al.
MODERATED POSTER PRESENTATION Open Access
Giant cell myocarditis in the CMR era
Tora Leong
*, Joyce Wong, Alexandra Rice, Mamdouh Zidan, Andrew Hamilton, Ben Ariff, Ruth Chester,
Shelley L Rahman Haley, Andrew Kelion, Margaret M Burke, Andrew G Mitchell, Nicholas Banner, Tarun K Mittal
From 15th Annual SCMR Scientific Sessions
Orlando, FL, USA. 2-5 February 2012
Summary
Our series of 5 cases of histologically-proven Giant cell
myocarditis with concurrent CMR shows a pattern of
late gadolinium enhancement which tends to be wide-
spread involving all layers of the myocardium.
Background
Giant cell myocarditis (GCM) is a rare condition with
paucity of data, particularly on diagnosis, prognosis and
morphological correlation. We sought to review cases of
histologically-proven GCM to examine their presenta-
tion and investigations, and in particular, the potential
role of cardiac magnetic resonance (CMR) imaging in
the diagnosis.
Methods
Cases of histologically-proven GCM presenting to our
institution, a national transplant center, who had con-
current CMR imaging were identified. CMR findings
were evaluated from the initial and follow-up scans for
ventricular volumes, function, and late gadolinium
enhancement (LGE) on an advanced post-processing
workstation.
Results
5 patients with histologically-proven GCM had CMR
performed with 2 having repeat CMR. 4 out of the 5
patients were in cardiogenic shock at the time of biopsy
(Patients No: 1, 2, 4 and 5). Most patients were initially
too unwell for CMR. For the 5 patients, their times
from presentation at our institution to time of endo-
myocardial biopsy (and initiation of treatment soon
after) were 0, 3, 11, 0 and 8 days respectively while their
times from presentation to first CMR were 12, 31, 9, 56
and 545 days respectively. Table 1 summarizes the CMR
findings of these 5 patients and their follow-up. They
had moderate to severe reduction in left ventricular
(LV) systolic function largely due to increase in end-sys-
tolic volumes (ESV) with the end-diastolic dimensions
remaining within normal limits. All patients had LGE
affecting the myocardium of the LV with multi-focal
involvement of all layers of myocardium with no seg-
mental predisposition. 3 patients also had LGE in the
right ventricular (RV) myocardium. In the 2 patients
who had follow-up CMR, there was deterioration in LV
EF due to increasing LV ESV, as well as increasing right
ventricular (RV) volumes in the follow-up CMR. These
2 patients received steroids and their immunosuppres-
sion regime were azathioprine and ciclosprin (Patient
No: 3), and rATG (Patient No: 4). For one of the
patients, follow-up biopsy did not show active GCM,
raising the possibility of deterioration in LV EF from
adverse remodeling.
Conclusions
In the largest available CMR series of histologically-pro-
ven GCM, LGE on CMR imaging tends to be wide-
spread involving all layers of the myocardium as
opposed to the typical patterns of ‘classical’ myocarditis.
This was representative of extensive inflammation and
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CMR Findings (Median, IQR) LV EDV (ml) LV ESV (ml) LV EF (%) RV EDV
(ml) RV ESV (ml) RV EF (%)
158 (133, 175) 98 (75, 108) 39 (39, 53) 140 (123, 145) 63
(61, 75) 53 (49, 58)
LGE Patterns: Patient No: 1 Patient No: 2 Patient No: 3 Patient No: 4
Patient No: 5
Multifocal mid-wall LGE. Focal sub-endocardial LGE at LV apex and mid-
ventricle. Multifocal mid-wall LGE. Thinning of inferior wall at mid-
ventricular level. Widespread mid-wall and sub-epicardial LGE with
microaneurysms and RV involvement. Widespread mid-wall LGE and
extensive sub-epicardial inferior wall LGE. RV involvement. Near global
sub-endocardial LGE. RV involvement.
CMR Interval changes: Patient No: 3 LV EDV change LV ESV change LV EF
change RV EDV change RV ESV change RV EF change Patient No: 4 LV
EDV change LV ESV change LV EF change RV EDV change RV ESV change
RV EF change
+5 ml +15 ml -22% +13 ml +24 ml -10% +43 ml +56 ml -35% +53 ml
+19 ml +2%
Figure 1 shows (a) the widespread mid-wall LGE in the left ventricle on CMR, (b) lateral wall fibrosis on the explant specimen (H&E, x20), (c)
Giant cell myocarditis in pre-transplant diagnostic endomyocardial biopsy (H&E, x200) of Patient No: 4 who had CMR and who subsequently
underwent cardiac transplantation.
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